Top Markets
#1 Pleasing Gold Pleasing Gold +1,543.14%
#2 PulseChain PulseChain +57.40%
#3 Ontology Gas Ontology Gas +36.19%
#4 Merlin's Seal BTC Merlin's Seal BTC +31.77%
#5 BOOK OF MEME BOOK OF MEME +30.30%
#6 Collect on Fanable Collect on Fanable +24.02%
#7 Neiro Neiro +20.79%
#8 Unit Pump Unit Pump +20.03%
#9 Pump.fun Pump.fun +20.03%
#10 Nockchain Nockchain +19.80%
Coin of the day
Pleasing Gold Pleasing Gold
Instellingen
Taal
DUTCH
Valuta
USD
Thema
PharmAust Limited PharmAust Limited

PharmAust Limited

PAA
Rang in aandelen #26700
Operating internationally, including in Switzerland, Australia, Sweden, and the... Operating internationally, including in Switzerland, Australia, Sweden, and the United States, PharmAust Limited specializes in developing targeted cancer treatments for both human and animal applications. The company also cultivates intellectual property in drug discovery, addressing a range of cancers and neurological conditions. Its primary therapeutic candidate is Monepantel (MPL), a small molecule compound currently undergoing Phase II clinical trials for cancer treatment. Beyond its drug development pipeline, PharmAust provides synthetic and medicinal chemistry products and expert services to the global drug discovery and pharmaceutical sectors. The firm also holds a research agreement with the Walter and Eliza Hall Institute, investigating in vitro the effects of MPL on human T-lymphotrophic virus-1 (HTLV-1) infections. Established in 2000, PharmAust Limited is headquartered in Bentley, Australia.
Aandeelprijs
$0.12164306
Laatst gesynchroniseerd: 2024-11-11
Marktkapitalisatie
$38.53M
Verandering (1 dag)
-4.14%
Verandering (1 jaar)
0.00%
Land
AU
Handel PharmAust Limited (PAA)

Categorie

Healthcare
P/B-ratio voor PharmAust Limited (PAA)
P/B-ratio op August 2026 TTM: 8.34
Volgens de meest recente financiële rapporten en aandelenkoers van PharmAust Limited is de huidige P/B-ratio (TTM) 8.34. Eind 2024 had het bedrijf een P/B-ratio van 7.07.
P/B-ratiohistoriek voor PharmAust Limited van 2001 tot 2026
P/B-ratio aan het einde van elk jaar
Jaar P/B-ratio Wijzigen
2026 (TTM) 8.34 -66.96%
2025 25.24 257.09%
2024 7.07 14.20%
2023 6.19 118.92%
2022 2.83 -12.60%
2021 3.24 -39.88%
2020 5.38 357.35%
2019 1.18 54.04%
2018 0.76 -23.38%
2017 1.00 -25.35%
2016 1.34 27.23%
2015 1.05 -36.35%
2014 1.65 -90.55%
2013 17.45 671.52%
2012 2.26 -68.36%
2011 7.15 99.09%
2010 3.59 333.85%
2009 0.83 5.81%
2008 0.78 -13.33%
2007 0.90 -33.57%
2006 1.36 -44.16%
2005 2.43 -64.38%
2004 6.83 667.26%
2003 0.89 -50.23%
2002 1.79 19.65%
2001 1.49 0.00%
P/B-ratio voor vergelijkbare bedrijven of concurrenten
Bedrijf P/B-ratio Verschil in P/B-ratio Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -23.94%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -25.15%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -69.95%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -55.52%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH